Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 1009
TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144614(US8969586, 1 | US9598436, 1)
Affinity DataIC50: 1.10nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144616(US8969586, 6 | US9598436, 6)
Affinity DataIC50: 3.20nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144623(US8969586, 86 | US9598436, 86)
Affinity DataIC50: 3.90nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144627(US8969586, 103 | US9598436, 103)
Affinity DataIC50: 4nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144626(US8969586, 99 | US9598436, 99)
Affinity DataIC50: 4nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144625(US8969586, 98 | US9598436, 98)
Affinity DataIC50: 8nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144620(US8969586, 52 | US9598436, 52)
Affinity DataIC50: 42nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144619(US8969586, 30 | US9598436, 30)
Affinity DataIC50: 48nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144628(US8969586, 109 | US9598436, 109)
Affinity DataIC50: 56nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144618(US8969586, 26 | US9598436, 26)
Affinity DataIC50: 65nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144624(US8969586, 94 | US9598436, 94)
Affinity DataIC50: 76nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144631(US8969586, 129 | US9598436, 129)
Affinity DataIC50: 79nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144617(US8969586, 14 | US9598436, 14)
Affinity DataIC50: 192nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144630(US8969586, 128 | US9598436, 128)
Affinity DataIC50: 251nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144615(US8969586, 4 | US9598436, 4)
Affinity DataIC50: 357nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM302871(3-(2-Methoxyethoxy)-7-(4-methylpyridin-3-yl)benzo[...)
Affinity DataIC50: 524nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144621(US8969586, 57 | US9598436, 57)
Affinity DataIC50: 524nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM144629(US8969586, 124 | US9598436, 124)
Affinity DataIC50: 611nMAssay Description:The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 μl prepared from 7.5 μl additions of microsomes (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent